eBioMedicine publishes biomedical research from preclinical studies to early-phase clinical trials. We focus on human health determinants, new therapeutic targets, treatments, biomarkers, and diagnostic tools.
Our goal is to advance knowledge in biomedical disciplines, fostering collaboration between scientists, researchers, and healthcare professionals.
Find out more via eBioMedicine's homepage.
🖼️ Image credit: Neil Webb
Company Details
- Industry
- Book And Periodical Publishing
- NAICS
-
Publishing Industries (except Internet)Newspaper, Periodical, Book, and Directory PublishersDirectory and Mailing List PublishersOther PublishersGreeting Card PublishersAll Other Publishers
- Competitors
- The Lancet Healthy Longevity, The Lancet Psychiatry, eClinicalMedicine – The Lancet Discovery Science, The Lancet Rheumatology, The Lancet Haematology, The Lancet Planetary Health, The Lancet Infectious Diseases, The Lancet Group, The Lancet Gastroenterology & Hepatology, The Lancet Child & Adolescent Health.
Ebiomedicine – The Lancet Discovery Science Questions
Ebiomedicine – The Lancet Discovery Science's website is https://www.thelancet.com/journals/ebiom/home
Ebiomedicine – The Lancet Discovery Science's LinkedIn profile is https://www.linkedin.com/company/ebiom
Ebiomedicine – The Lancet Discovery Science's industry is
Book and Periodical Publishing
Ebiomedicine – The Lancet Discovery Science's top competitors are
The Lancet Healthy Longevity,
The Lancet Psychiatry,
Eclinicalmedicine – The Lancet Discovery Science,
The Lancet Rheumatology,
The Lancet Haematology,
The Lancet Planetary Health,
The Lancet Infectious Diseases,
The Lancet Group,
The Lancet Gastroenterology & Hepatology,
The Lancet Child & Adolescent Health.
Ebiomedicine – The Lancet Discovery Science's categories are Book and Periodical Publishing
